SG Americas Securities’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-24,668
| Closed | -$75K | – | 3676 |
|
|
2024
Q4 | $75K | Buy |
24,668
+11,252
| +84% | +$32.7K | ﹤0.01% | 2817 |
|
|
2024
Q3 | $34K | Buy |
+13,416
| New | +$40.6K | ﹤0.01% | 3308 |
|
|
2024
Q2 | – | Sell |
-10,740
| Closed | -$57K | – | 3196 |
|
|
2024
Q1 | $57K | Buy |
+10,740
| New | +$57.8K | ﹤0.01% | 2725 |
|
|
2021
Q4 | – | Sell |
-15,091
| Closed | -$106K | – | 3702 |
|
|
2021
Q3 | $106K | Buy |
+15,091
| New | +$113K | ﹤0.01% | 3643 |
|
|
2021
Q2 | – | Sell |
-14,983
| Closed | -$146K | – | 3142 |
|
|
2021
Q1 | $146K | Buy |
+14,983
| New | +$167K | ﹤0.01% | 2875 |
|
|
2020
Q4 | – | Sell |
-31,616
| Closed | -$319K | – | 3438 |
|
|
2020
Q3 | $319K | Buy |
+31,616
| New | +$322K | ﹤0.01% | 1901 |
|
|
2020
Q2 | – | Sell |
-23,082
| Closed | -$195K | – | 3808 |
|
|
2020
Q1 | $195K | Buy |
+23,082
| New | +$224K | ﹤0.01% | 2520 |
|
|
2019
Q4 | – | Sell |
-102,825
| Closed | -$1.11M | – | 3399 |
|
|
2019
Q3 | $1.11M | Buy |
+102,825
| New | +$1.11M | 0.01% | 1351 |
|
|
2019
Q2 | – | Sell |
-5,402
| Closed | -$210K | – | 3329 |
|
|
2019
Q1 | $210K | Buy |
+5,402
| New | +$165K | ﹤0.01% | 2530 |
|
|
2018
Q3 | – | Sell |
-1,785
| Closed | -$106K | – | 3380 |
|
|
2018
Q2 | $106K | Sell |
1,785
-7,380
| -81% | -$428K | ﹤0.01% | 3041 |
|
|
2018
Q1 | $624K | Buy |
9,165
+2,907
| +46% | +$218K | 0.01% | 1730 |
|
|
2017
Q4 | $619K | Buy |
6,258
+3,624
| +138% | +$406K | 0.01% | 1702 |
|
|
2017
Q3 | $315K | Buy |
+2,634
| New | +$245K | ﹤0.01% | 2187 |
|
|
2016
Q4 | – | Sell |
-3,834
| Closed | -$257K | – | 3371 |
|
|
2016
Q3 | $257K | Buy |
+3,834
| New | +$194K | ﹤0.01% | 2278 |
|
|
2015
Q4 | – | Sell |
-2,378
| Closed | -$179K | – | 2906 |
|
|
2015
Q3 | $179K | Sell |
2,378
-3,855
| -62% | -$365K | ﹤0.01% | 1520 |
|
|
2015
Q2 | $728K | Buy |
+6,233
| New | +$1.13M | ﹤0.01% | 1238 |
|
|
2015
Q1 | – | Sell |
-2,217
| Closed | -$420K | – | 2949 |
|
|
2014
Q4 | $420K | Buy |
2,217
+1,740
| +365% | +$386K | ﹤0.01% | 1781 |
|
|
2014
Q3 | $114K | Buy |
+477
| New | +$97.9K | ﹤0.01% | 2304 |
|
|
2013
Q4 | – | Sell |
-4,270
| Closed | -$229K | – | 2910 |
|
|
2013
Q3 | $229K | Buy |
+4,270
| New | +$230K | ﹤0.01% | 2096 |
|
Other funds holding PBYI
ACA
KCM
SG Americas Securities's PBYI Position: Q1 2025 in Review
SG Americas Securities sold out of Puma Biotechnology (PBYI) in Q1 2025, closing a stake of 24,668 shares — an estimated $75K sold.
SG Americas Securities first reported a position in PBYI in Q3 2013 and held it in 19 quarters. The position peaked at $1.11M in Q3 2019. 116 funds tracked by Wall St. Rank hold PBYI as of Q1 2025.
- SG Americas Securities reported no remaining Puma Biotechnology position as of Q1 2025 after selling out during the quarter.
- SG Americas Securities sold 24,668 Puma Biotechnology shares in Q1 2025, an estimated $75K.
- SG Americas Securities first reported a position in Puma Biotechnology in Q3 2013 and held it in 19 quarters.
- SG Americas Securities's Puma Biotechnology position peaked at $1.11M in Q3 2019.
- 116 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2025.
Based on SG Americas Securities's 13F filing for Q1 2025, filed 15 Apr 2025.